<DOC>
	<DOCNO>NCT01635361</DOCNO>
	<brief_summary>About 25 % medicine prescribe long term condition take direct , approximately 15 % people receive new medicine take , , dose . The New Medicine Service ( NMS ) community pharmacy service start England October 2011 involve pharmacist provide additional support patient start new medicine breathing problem ( asthma &amp; COPD ) , high blood pressure , adult onset diabetes medicine reduce blood clotting . It aim improve way patient take medicine improve outcome reduce cost National Health Service ( NHS ) . The investigator assess effectiveness cost effectiveness NMS use research study people receive NMS , wo n't , The investigator look effect NMS problem medicine , medicine take use NHS general . Data collect East Midlands , South Yorkshire London area . The investigator recruit 500 patient range different pharmacy follow six , ten twenty six week start new medicine ass effect medicine take behaviour , patient ' report problem medicine , referral General Practitioner ( GP ) use NHS resource . The investigator compare data gather study collect routinely pharmacy England provide wider estimate cost effectiveness . The investigator also explore NMS service implement pharmacy . A sample patient main study follow detail . This involve record consultation pharmacist also interview patient experience service . The investigator interview patient GP investigate view service . The investigator also try understand people decline invitation NMS</brief_summary>
	<brief_title>Understanding Appraising New Medicine Service England</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Community dwell patient eligible NMS ( age 14 year start new medicine asthma/COPD , diabetes ( Type 2 ) , antiplatelet/anticoagulation hypertension ) . Patients collect repeat prescription medicine ( i.e . new ) asthma/COPD , type 2 diabetes mellitus ( T2DM ) , antiplatelets/anticoagulants hypertension Patients collect medicine change previous medicine involve dosage formulation change Participants unable understand patient/participant study document Participants unable unwilling provide write consent / assent</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>